artenimol has been researched along with Alcoholic Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, M; Chen, X; Jin, H; Lian, N; Shao, J; Zhang, F; Zheng, S | 1 |
| Lu, C; Shao, J; Xu, W; Yao, L; Zhang, F; Zheng, S | 1 |
2 other study(ies) available for artenimol and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Dihydroartemisinin attenuates alcoholic fatty liver through regulation of lipin-1 signaling.
Topics: Animals; Antimalarials; Apoptosis; Artemisinins; Cells, Cultured; Endoplasmic Reticulum Stress; Fatty Liver, Alcoholic; Gene Expression Regulation; Hepatocytes; Lipid Metabolism; Male; Mice; Mice, Inbred ICR; Phosphatidate Phosphatase; Signal Transduction | 2019 |
Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
Topics: Animals; Artemisinins; Fatty Liver, Alcoholic; Liver Diseases, Alcoholic; Male; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear | 2017 |